Market Overview

UPDATE: JP Morgan Downgrades CME Group to Underweight on Falling Volumes

Related CME
Fast Money Picks For September 18 - Metlife Inc, CME Group Inc And More
UPDATE: GFI Issues Response to Unsolicited Bid from BGC, Sees Offer as Reasonably Leading to Superior Proposal, Continues to support Deal with CME
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

JP Morgan reduced its rating on CME Group (NASDAQ: CME) from Neutral to Underweight and reduced its price target from $56.50 to $54.

JP Morgan said, "We see a disconnect between the fundamentals in CME's core business and the price appreciation and valuation of its stock. While we see the opportunities for both OTC clearing revenue and the migration to listed trading for interest rates, we feel that those opportunities could develop over a longer period of time, leaving investors to focus on the market-condition-driven deterioration in volumes. While a special dividend provides support to the stock, we see the potential for downside with limited upside over the next 6-12 months."

CME Group closed at $59.35 on Thursday.

Latest Ratings for CME

DateFirmActionFromTo
Sep 2014Keefe Bruyette & WoodsMaintainsOutperform
Sep 2014Deutsche Bank
Sep 2014Deutsche BankInitiates Coverage onBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters